Stay updated on Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page.

Latest updates to the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check21 days agoChange DetectedRevision label updated from v3.4.3 to v3.5.0. This seems to reflect a system version update with no apparent changes to the study details.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3. No study details or user-facing content appear to be affected.SummaryDifference0.1%

- Check63 days agoChange DetectedAdded Revision: v3.4.2; removed the government operating-status notice and the previous Revision: v3.4.1 banner.SummaryDifference0.5%

- Check70 days agoChange DetectedTwo additions include a government funding notice and a new revision label (Revision: v3.4.1), while the previous revision label (v3.4.0) was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check77 days agoChange DetectedThe changes include a UI enhancement to show the glossary, capitalization adjustments in a QC-related label, and a version label update from v3.3.4 to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check92 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the page; this appears to be an internal version update with no changes to study content or critical information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab for NSCLC Induction: PRINCEPS Clinical Trial page.